Tech Company Financing Transactions
Novadip Biosciences Funding Round
Novadip Biosciences closed a $12 million funding round on 9/21/2026. Investors included New Science Ventures, Fund+ and Invest BW.
Transaction Overview
Company Name
Announced On
9/21/2026
Transaction Type
Venture Equity
Amount
$11,980,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance its lead program, NVD003, an autologous cell-based therapy, through the final stage of clinical development and preparation for regulatory submission.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Watson & Crick Hill, Rue Granbonpré 11,
Mont-Saint-Guibert, 1435
Belgium
Mont-Saint-Guibert, 1435
Belgium
Phone
Website
Email Address
Overview
Novadip is transforming the lives of patients using its unique "3M3" tissue regeneration technology platform. Based on the scientific discoveries of Prof. Dr. Denis Dufrane, Novadip is a spin-off company from Université Catholique de Louvain (UCLouvain) and St. Luc University Hospital. The creation of Novadip was supported by the Louvain Technology Transfer Office (LTTO), Sopartec and VIVES II. Using our unique 3M3 tissue regeneration platform, which utilizes adipose-derived stem cells within a 3-dimensional extracellular matrix, to drive multiple product classes, Novadip's mission is to provide innovative solutions for patients with limited or no effective treatment options.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 9/21/2026: Rainmaker Technology venture capital transaction
Next: 9/21/2026: Paymob venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








